Search clinical trials for: EXL01

Total 7 results

Institut Claudius Regaud

Withdrawn

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA) (PROSTIRNA)

Prostatic Cancer, Castration-Resistant

France
Hospices Civils de Lyon
Exeliom Biosciences

Not yet recruiting

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (LIVEDIFF)

Clostridioides Difficile Infection | Recurrent Infection

France
Institute of Hematology & Blood Diseases Hospital...
Shanghai Vitalgen BioPharma Co., Ltd.

Recruiting

Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells

Thalassemia Major | Thalassemia, Beta

China
Exeliom Biosciences
Alimentiv Inc.

Recruiting

EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease (MAINTAIN)

Crohn Disease

Poland, Belgium
Pergamum AB

Completed

Study of PXL01 Versus Placebo to Inhibit Adhesion Formation After Flexor Tendon Surgery (PHSU02)

Surgical Adhesions

Denmark, Germany, Sweden
PharmaSurgics AB

Completed

Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers

Post-surgery Adhesion Formation

Sweden
GERCOR - Multidisciplinary Oncology Cooperative...

Not yet recruiting

First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer (BIG)

Gastric Cancer

3

Subscribe